TrialThe Journal of pharmacology and experimental therapeutics2025
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation.
Noboru Kaneko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.